...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: I'll believe
4
Oct 30, 2022 11:08AM

Oct 30, 2022 11:26AM
3
Oct 30, 2022 12:07PM

 "think Don mentioned deals are generating as many $$$ at this time?"

should have read "are not"

1
Oct 30, 2022 12:56PM
2
Oct 30, 2022 01:22PM
2
Oct 30, 2022 01:47PM
2
Oct 30, 2022 03:42PM
1
Oct 30, 2022 05:08PM
Share
New Message
Please login to post a reply